CN Stock MarketDetailed Quotes
301520 Anhui Wanbang Pharmaceutical Technology
- 39.92
- -0.35-0.87%
Market Closed Jul 17 15:00 CST
2.66BMarket Cap23.59P/E (TTM)
40.88High38.08Low9.06KlotVolume40.00Open40.27Pre Close36.65MTurnover5.44%Turnover Ratio24.63P/E (Static)66.67MShares89.5052wk High1.82P/B665.33MFloat Cap37.8452wk Low48.32Limit Up16.67MShs Float89.50Historical High32.22Limit Down6.95%Amplitude37.84Historical Low0.50Dividend TTM40.43Avg Price4.05KlotAsk1.25%Div YieldTTM100Lot Size4.71KlotBid
Anhui Wanbang Pharmaceutical Technology Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 9.69%74.2M | 34.10%309.14M | 35.66%219.68M | 55.83%150.08M | --67.64M | 23.65%230.53M | --161.94M | 20.71%96.31M | ---- | 54.99%186.43M |
| Refunds of taxes and levies | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash received relating to other operating activities | 696.30%3.49M | 12.02%14.63M | -33.26%7.42M | -15.78%3.28M | --438.8K | 27.45%13.06M | --11.12M | -42.31%3.9M | ---- | 19.16%10.25M |
| Cash inflows from operating activities | 14.12%77.7M | 32.92%323.77M | 31.23%227.1M | 53.04%153.36M | --68.08M | 23.85%243.59M | --173.06M | 15.79%100.21M | ---- | 52.60%196.68M |
| Goods services cash paid | 27.80%42.66M | 50.34%153.59M | 38.93%99.29M | 71.89%68.29M | --33.38M | 26.75%102.17M | --71.47M | 8.21%39.73M | ---- | 91.94%80.6M |
| Staff behalf paid | 11.44%26M | 49.61%64.98M | 41.11%48.07M | 39.77%34.6M | --23.33M | 47.01%43.44M | --34.07M | 51.78%24.75M | ---- | 45.22%29.55M |
| All taxes paid | 9.17%5.85M | -11.34%14.78M | -10.73%10.81M | -2.72%7.06M | --5.36M | -9.90%16.67M | --12.11M | -25.40%7.26M | ---- | 78.93%18.5M |
| Cash paid relating to other operating activities | -10.89%2.62M | 105.62%18.5M | 214.70%19.46M | 62.92%7.73M | --2.94M | -28.59%9M | --6.18M | -42.83%4.75M | ---- | 38.63%12.6M |
| Cash outflows from operating activities | 18.64%77.13M | 47.05%251.85M | 43.45%177.63M | 53.86%117.68M | --65.01M | 21.25%171.26M | --123.82M | 7.65%76.49M | ---- | 72.75%141.25M |
| Net cash flows from operating activities | -81.58%566.21K | -0.55%71.92M | 0.49%49.48M | 50.42%35.68M | 151.69%3.07M | 30.47%72.32M | --49.23M | 53.18%23.72M | ---5.95M | 17.64%55.43M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | -67.70%354.35M | -85.07%126.75M | -56.69%255.25M | --208.45M | -11.71%1.1B | --848.98M | 19.71%589.33M | ---- | 209.86%1.24B |
| Cash received from returns on investments | ---- | -25.51%2.37M | -17.32%2.01M | 10.72%1.74M | --813.02K | 71.31%3.18M | --2.43M | 134.91%1.57M | ---- | 55.10%1.85M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash inflows from investing activities | ---- | -67.58%356.72M | -84.88%128.76M | -56.51%256.99M | --209.26M | -11.59%1.1B | --851.41M | 19.87%590.9M | ---- | 209.40%1.24B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -49.12%15.32M | 69.57%85.97M | 164.59%69.15M | 679.31%52.98M | --30.11M | 225.06%50.7M | --26.13M | -33.62%6.8M | ---- | 126.80%15.6M |
| Cash paid to acquire investments | ---- | 18.82%1.3B | -67.30%277.64M | -56.69%255.25M | --208.45M | -11.71%1.1B | --848.98M | 19.71%589.33M | ---- | 234.15%1.24B |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash outflows from investing activities | -93.58%15.32M | 21.06%1.39B | -60.37%346.79M | -48.30%308.23M | --238.56M | -8.78%1.15B | --875.11M | 18.62%596.13M | ---- | 232.20%1.26B |
| Net cash flows from investing activities | 47.71%-15.32M | -2,073.07%-1.03B | -819.69%-218.03M | -879.74%-51.24M | ---29.29M | -245.80%-47.52M | ---23.71M | 45.37%-5.23M | ---- | -158.56%-13.74M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | --1.05B | --1.05B | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash from borrowing | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash received relating to other financing activities | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash inflows from financing activities | ---- | --1.05B | --1.05B | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Borrowing repayment | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Dividend interest payment | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash payments relating to other financing activities | ---- | 20,584.96%24.82M | --18.86M | -50.00%30K | --30K | 33.33%120K | --0 | --60K | ---- | --90K |
| Cash outflows from financing activities | ---- | 20,584.96%24.82M | --18.86M | -50.00%30K | --30K | 33.33%120K | --0 | --60K | ---- | --90K |
| Net cash flows from financing activities | ---- | 856,865.06%1.03B | --1.03B | 50.00%-30K | ---30K | -33.33%-120K | --0 | ---60K | ---- | -100.21%-90K |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | 43.81%-14.75M | 172.85%67.34M | 3,290.76%865.52M | -184.61%-15.59M | ---26.25M | -40.67%24.68M | --25.53M | 211.80%18.43M | ---- | -63.58%41.6M |
| Add:Begin period cash and cash equivalents | 36.18%253.5M | 15.29%186.15M | 15.29%186.15M | 15.29%186.15M | --186.15M | 34.70%161.47M | --161.47M | 34.70%161.47M | ---- | 2,024.20%119.87M |
| End period cash equivalent | 49.31%238.75M | 36.18%253.5M | 462.40%1.05B | -5.19%170.56M | --159.9M | 15.29%186.15M | --187M | 43.03%179.9M | ---- | 34.70%161.47M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Rong Shing Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Shing Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Shing Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg